Table 1. Cannabinoid Derived Pharmaceutical Consumption Value & CAGR: China VS Global, 2019-2030, US$ Million

Table 2. Cannabinoid Derived Pharmaceutical Market Restraints

Table 3. Cannabinoid Derived Pharmaceutical Market Trends

Table 4. Cannabinoid Derived Pharmaceutical Industry Policy

Table 5. Global Cannabinoid Derived Pharmaceutical Revenue by Company, 2019-2024, US$ million, Ranked Based on Revenue in 2022

Table 6. Global Cannabinoid Derived Pharmaceutical Revenue Share by Company, 2019-2024, Ranked by Data of 2022

Table 7. Global Cannabinoid Derived Pharmaceutical Sales Quantity by Company, (2019-2024) & (K Units), Ranked Based on Sales in 2022

Table 8. Global Cannabinoid Derived Pharmaceutical Sales Quantity by Company, 2019-2024, Ranked by Data of 2022

Table 9. Global Cannabinoid Derived Pharmaceutical Average Selling Price (ASP) by Company, (2019-2024) & (US$/Unit)

Table 10. Global Cannabinoid Derived Pharmaceutical Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Cannabinoid Derived Pharmaceutical Mergers & Acquisitions, Expansion Plans

Table 12. Global Cannabinoid Derived Pharmaceutical Manufacturers Product Type

Table 13. Head Office and Cannabinoid Derived Pharmaceutical Production Site of Key Manufacturer

Table 14. Cannabinoid Derived Pharmaceutical Capacity of Major Manufacturers and Future Plan

Table 15. China Cannabinoid Derived Pharmaceutical Revenue by Company, 2019-2024, US$ million, Ranked Based on Revenue in 2022

Table 16. China Cannabinoid Derived Pharmaceutical Sales Quantity by Company, (2019-2024) & (K Units), Ranked Based on Sales in 2022

Table 17. China Cannabinoid Derived Pharmaceutical Sales Quantity by Company, 2019-2024, Ranked by Data of 2022

Table 18. Global Cannabinoid Derived Pharmaceutical Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)

Table 19. Global Cannabinoid Derived Pharmaceutical Production by Region, 2019-2024, (K Units)

Table 20. Global Cannabinoid Derived Pharmaceutical Production Forecast by Region, 2024-2029, (K Units)

Table 21. Global Key Players of Cannabinoid Derived Pharmaceutical Upstream (Raw Materials)

Table 22. Global Cannabinoid Derived Pharmaceutical Typical Customers

Table 23. Cannabinoid Derived Pharmaceutical Typical Distributors

Table 24. By Type, Global Cannabinoid Derived Pharmaceutical Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 25. By Application, Global Cannabinoid Derived Pharmaceutical Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 26. By Region, Global Cannabinoid Derived Pharmaceutical Consumption Value, 2019 VS 2024 VS 2030, US$ Million

Table 27. By Region, Global Cannabinoid Derived Pharmaceutical Consumption Value, 2019-2030, US$ Million

Table 28. By Region, Global Cannabinoid Derived Pharmaceutical Sales Quantity, 2019-2030, (K Units)

Table 29. By Country, Global Cannabinoid Derived Pharmaceutical Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 30. By Country, Global Cannabinoid Derived Pharmaceutical Consumption Value, 2019-2030, US$ Million

Table 31. By Country, Global Cannabinoid Derived Pharmaceutical Consumption Value Market Share, 2019-2030

Table 32. By Country, Global Cannabinoid Derived Pharmaceutical Sales Quantity, 2019-2030, (K Units)

Table 33. By Country, Global Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2019-2030

Table 34. Cara Therapeutics Inc Company Information, Head Office, Market Area, and Industry Position

Table 35. Cara Therapeutics Inc Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

Table 36. Cara Therapeutics Inc Cannabinoid Derived Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 37. Cara Therapeutics Inc Company Profile and Main Business

Table 38. Cara Therapeutics Inc Recent Developments

Table 39. Arena Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 40. Arena Pharmaceuticals Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

Table 41. Arena Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 42. Arena Pharmaceuticals Company Profile and Main Business

Table 43. Arena Pharmaceuticals Recent Developments

Table 44. Cannabics Pharmaceuticals Inc Company Information, Head Office, Market Area, and Industry Position

Table 45. Cannabics Pharmaceuticals Inc Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

Table 46. Cannabics Pharmaceuticals Inc Cannabinoid Derived Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 47. Cannabics Pharmaceuticals Inc Company Profile and Main Business

Table 48. Cannabics Pharmaceuticals Inc Recent Developments

Table 49. Echo Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 50. Echo Pharmaceuticals Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

Table 51. Echo Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 52. Echo Pharmaceuticals Company Profile and Main Business

Table 53. Echo Pharmaceuticals Recent Developments

Table 54. Gw Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 55. Gw Pharmaceuticals Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

Table 56. Gw Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 57. Gw Pharmaceuticals Company Profile and Main Business

Table 58. Gw Pharmaceuticals Recent Developments

Table 59. Inmed Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 60. Inmed Pharmaceuticals Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

Table 61. Inmed Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 62. Inmed Pharmaceuticals Company Profile and Main Business

Table 63. Inmed Pharmaceuticals Recent Developments

Table 64. Insys Therapeutics Inc Company Information, Head Office, Market Area, and Industry Position

Table 65. Insys Therapeutics Inc Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

Table 66. Insys Therapeutics Inc Cannabinoid Derived Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 67. Insys Therapeutics Inc Company Profile and Main Business

Table 68. Insys Therapeutics Inc Recent Developments

Table 69. Larapharm Company Information, Head Office, Market Area, and Industry Position

Table 70. Larapharm Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

Table 71. Larapharm Cannabinoid Derived Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 72. Larapharm Company Profile and Main Business

Table 73. Larapharm Recent Developments

Table 74. Mgc Pharmaceuticals Ltd Company Information, Head Office, Market Area, and Industry Position

Table 75. Mgc Pharmaceuticals Ltd Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

Table 76. Mgc Pharmaceuticals Ltd Cannabinoid Derived Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 77. Mgc Pharmaceuticals Ltd Company Profile and Main Business

Table 78. Mgc Pharmaceuticals Ltd Recent Developments

Table 79. One World Cannabis Company Information, Head Office, Market Area, and Industry Position

Table 80. One World Cannabis Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

Table 81. One World Cannabis Cannabinoid Derived Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 82. One World Cannabis Company Profile and Main Business

Table 83. One World Cannabis Recent Developments

Table 84. Orpheus Medica Company Information, Head Office, Market Area, and Industry Position

Table 85. Orpheus Medica Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

Table 86. Orpheus Medica Cannabinoid Derived Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 87. Orpheus Medica Company Profile and Main Business

Table 88. Orpheus Medica Recent Developments

Table 89. Receptor Life Sciences Company Information, Head Office, Market Area, and Industry Position

Table 90. Receptor Life Sciences Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

Table 91. Receptor Life Sciences Cannabinoid Derived Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 92. Receptor Life Sciences Company Profile and Main Business

Table 93. Receptor Life Sciences Recent Developments

Table 94. Respirerx Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 95. Respirerx Pharmaceuticals Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

Table 96. Respirerx Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 97. Respirerx Pharmaceuticals Company Profile and Main Business

Table 98. Respirerx Pharmaceuticals Recent Developments

Table 99. Tetra Bio-Pharma Company Information, Head Office, Market Area, and Industry Position

Table 100. Tetra Bio-Pharma Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

Table 101. Tetra Bio-Pharma Cannabinoid Derived Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 102. Tetra Bio-Pharma Company Profile and Main Business

Table 103. Tetra Bio-Pharma Recent Developments

Table 104. Cardiol Therapeutics Company Information, Head Office, Market Area, and Industry Position

Table 105. Cardiol Therapeutics Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

Table 106. Cardiol Therapeutics Cannabinoid Derived Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 107. Cardiol Therapeutics Company Profile and Main Business

Table 108. Cardiol Therapeutics Recent Developments

Table 109. United Cannabis Corporation Company Information, Head Office, Market Area, and Industry Position

Table 110. United Cannabis Corporation Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

Table 111. United Cannabis Corporation Cannabinoid Derived Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 112. United Cannabis Corporation Company Profile and Main Business

Table 113. United Cannabis Corporation Recent Developments

Table 114. Zynerba Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 115. Zynerba Pharmaceuticals Cannabinoid Derived Pharmaceutical Models, Specifications, and Application

Table 116. Zynerba Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 117. Zynerba Pharmaceuticals Company Profile and Main Business

Table 118. Zynerba Pharmaceuticals Recent Developments

List of Figures

Figure 1. Cannabinoid Derived Pharmaceutical Picture

Figure 2. Global Cannabinoid Derived Pharmaceutical Consumption Value, (US$ million) & (2019-2030)

Figure 3. Global Cannabinoid Derived Pharmaceutical Sales Quantity, (K Units) & (2019-2030)

Figure 4. Global Cannabinoid Derived Pharmaceutical Average Selling Price (ASP), (2019-2030) & (US$/Unit)

Figure 5. China Cannabinoid Derived Pharmaceutical Consumption Value, (US$ million) & (2019-2030)

Figure 6. China Cannabinoid Derived Pharmaceutical Sales Quantity (K Units) & (2019-2030)

Figure 7. China Cannabinoid Derived Pharmaceutical Average Selling Price (ASP), (US$/Unit) & (2019-2030)

Figure 8. By Consumption Value, China Cannabinoid Derived Pharmaceutical Market Share of Global, 2019-2030

Figure 9. By Sales Quantity, China Cannabinoid Derived Pharmaceutical Market Share of Global, 2019-2030

Figure 10. Global Cannabinoid Derived Pharmaceutical Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022

Figure 11. China Cannabinoid Derived Pharmaceutical Key Participants, Market Share, 2022

Figure 12. Global Cannabinoid Derived Pharmaceutical Capacity, Production and Capacity Utilization, 2019-2030

Figure 13. Global Cannabinoid Derived Pharmaceutical Capacity Market Share by Region, 2022 VS 2029

Figure 14. Global Cannabinoid Derived Pharmaceutical Production Market Share & Forecast by Region, 2019-2030

Figure 15. Cannabinoid Derived Pharmaceutical Industry Chain

Figure 16. Cannabinoid Derived Pharmaceutical Procurement Model

Figure 17. Cannabinoid Derived Pharmaceutical Sales Model

Figure 18. Cannabinoid Derived Pharmaceutical Sales Channels, Direct Sales, and Distribution

Figure 19. Cannabinoid Receptor Type 1 (CB1)

Figure 20. Cannabinoid Receptor Type 2 (CB2)

Figure 21. Others

Figure 22. By Type, Global Cannabinoid Derived Pharmaceutical Consumption Value, 2019-2030, US$ Million

Figure 23. By Type, Global Cannabinoid Derived Pharmaceutical Consumption Value Market Share, 2019-2030

Figure 24. By Type, Global Cannabinoid Derived Pharmaceutical Sales Quantity, 2019-2030, (K Units)

Figure 25. By Type, Global Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2019-2030

Figure 26. By Type, Global Cannabinoid Derived Pharmaceutical Average Selling Price (ASP), 2019-2030, (US$/Unit)

Figure 27. Epilepsy

Figure 28. Migraine

Figure 29. Multiple Sclerosis

Figure 30. Others

Figure 31. By Application, Global Cannabinoid Derived Pharmaceutical Consumption Value, 2019-2030, US$ Million

Figure 32. By Application, Global Cannabinoid Derived Pharmaceutical Consumption Value Market Share, 2019-2030

Figure 33. By Application, Global Cannabinoid Derived Pharmaceutical Sales Quantity, 2019-2030, (K Units)

Figure 34. By Application, Global Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2019-2030

Figure 35. By Application, Global Cannabinoid Derived Pharmaceutical Average Selling Price (ASP), 2019-2030, (US$/Unit)

Figure 36. By Region, Global Cannabinoid Derived Pharmaceutical Consumption Value Market Share, 2019-2030

Figure 37. By Region, Global Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2019-2030

Figure 38. North America Cannabinoid Derived Pharmaceutical Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 39. By Country, North America Cannabinoid Derived Pharmaceutical Consumption Value Market Share, 2022

Figure 40. Europe Cannabinoid Derived Pharmaceutical Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 41. By Country, Europe Cannabinoid Derived Pharmaceutical Consumption Value Market Share, 2022

Figure 42. Asia Pacific Cannabinoid Derived Pharmaceutical Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 43. By Country/Region, Asia Pacific Cannabinoid Derived Pharmaceutical Consumption Value Market Share, 2022

Figure 44. South America Cannabinoid Derived Pharmaceutical Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 45. By Country, South America Cannabinoid Derived Pharmaceutical Consumption Value Market Share, 2022

Figure 46. Middle East & Africa Cannabinoid Derived Pharmaceutical Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 47. U.S. Cannabinoid Derived Pharmaceutical Sales Quantity, 2019-2030, (K Units)

Figure 48. By Type, U.S. Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

Figure 49. By Application, U.S. Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

Figure 50. Europe Cannabinoid Derived Pharmaceutical Sales Quantity, 2019-2030, (K Units)

Figure 51. By Type, Europe Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

Figure 52. By Application, Europe Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

Figure 53. China Cannabinoid Derived Pharmaceutical Sales Quantity, 2019-2030, (K Units)

Figure 54. By Type, China Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

Figure 55. By Application, China Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

Figure 56. Japan Cannabinoid Derived Pharmaceutical Sales Quantity, 2019-2030, (K Units)

Figure 57. By Type, Japan Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

Figure 58. By Application, Japan Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

Figure 59. South Korea Cannabinoid Derived Pharmaceutical Sales Quantity, 2019-2030, (K Units)

Figure 60. By Type, South Korea Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

Figure 61. By Application, South Korea Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

Figure 62. Southeast Asia Cannabinoid Derived Pharmaceutical Sales Quantity, 2019-2030, (K Units)

Figure 63. By Type, Southeast Asia Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

Figure 64. By Application, Southeast Asia Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

Figure 65. India Cannabinoid Derived Pharmaceutical Sales Quantity, 2019-2030, (K Units)

Figure 66. By Type, India Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

Figure 67. By Application, India Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

Figure 68. Middle East & Africa Cannabinoid Derived Pharmaceutical Sales Quantity, 2019-2030, (K Units)

Figure 69. By Type, Middle East & Africa Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

Figure 70. By Application, Middle East & Africa Cannabinoid Derived Pharmaceutical Sales Quantity Market Share, 2022 VS 2029

Figure 71. Research Methodology

Figure 72. Breakdown of Primary Interviews

Figure 73. Bottom-up and Top-down Approaches

Figure 74. Top-down Approaches